CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the use of flavonoids as potential cancer treatments. By utilizing a microfluidic platform, it aims to create a stable nanoformulation for oral administration, enhancing the anticancer effects of flavonoids against colorectal cancer.
Colorectal cancer is among the most lethal and prevalent malignancies in the world.
Current treatment has limitations, such as adverse effects, drug resistance, metastasis, and recidivism.
Flavonoids such as Apigenin, Epigallocatechin-3-gallate, and Quercetin have demonstrated anticancer effects and alternatives for new treatments.
Flavonoids can suppress tumor growth, induce apoptosis, inhibit angiogenesis, and modulate cellular signaling pathways in development and progression.
Multiple flavon…
UNIVERSITAIR MEDISCH CENTRUM GRONINGEN
ACADEMISCH ZIEKENHUIS GRONINGEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
